含塞来昔布药物目前在欧盟被批准用于骨性关节炎、类风湿性关节炎和强直性脊柱炎症状的治疗。
Celecoxib-containing products are currently authorised in the European Union for the treatment of the symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.
突破了现有针刀的使用范围，适用于慢性软组织损伤、骨质增生 症、骨关节骨性强直进行闭合性手术松解。
The present invention is breakthrough existing needle knife using range, suitable for chronic soft tissue injury, hyperosteogeny and bone joint bony rigidity closing operation release.
应用推荐